Related Experiment Videos
Mechanisms of action of calcium antagonists in hypertension
Insights
Calcium plays a key role in blood pressure regulation. Calcium antagonists effectively lower blood pressure by reducing calcium influx and improving hemodynamics, making them suitable for hypertension treatment.
Area of Science:
- Cardiovascular Physiology
- Pharmacology
Background:
- Cytosolic free calcium concentrations regulate smooth muscle cell tension and vascular tone.
- Elevated calcium levels in platelets are observed in hypertensive patients, potentially reflecting vascular smooth muscle cell calcium levels.
- Essential hypertension involves increased systemic vascular resistance due to heightened calcium influx.
Purpose of the Study:
- To elucidate the role of calcium in hypertension.
- To evaluate the hemodynamic effects and therapeutic potential of calcium antagonists in managing hypertension.
Main Methods:
- Review of existing literature on calcium's role in vascular smooth muscle function and hypertension.
- Analysis of the mechanisms of action of calcium antagonists, including their effects on calcium influx and hemodynamics.
Main Results:
- Calcium antagonists reduce cytosolic free calcium concentrations by inhibiting transmembraneous calcium influx.
- These agents act as potent arterial vasodilators, lowering elevated systemic vascular resistance without significant sympathetic activation.
- Calcium antagonists improve intrarenal hemodynamics, leading to a diuretic effect and preventing volume retention.
- Interference with vasoconstrictor mechanisms, such as angiotensin and sympathetic pathways, contributes to their antihypertensive effects.
Conclusions:
- Calcium antagonists offer a favorable hemodynamic profile for hypertension management.
- They are effective in monotherapy for uncomplicated hypertension, particularly in older adults.
- Calcium antagonists are also suitable for treating hypertensive crisis.
Abstract:
Cytosolic free calcium concentrations determine the magnitude of tension development of smooth muscle cells and are pivotal for regulation of vascular smooth muscle tone and systemic vascular resistance. Elevated free calcium concentrations have been found in platelets from hypertensive patients, and platelet free calcium concentration, possibly an index of vascular smooth muscle cell free calcium concentration, correlated with blood pressure in normotensive and hypertensive subjects. Increased systemic vascular resistance in essential hypertension depends on increased calcium influx. Calcium antagonists lower cytosolic free calcium concentrations mainly through a reduction of transmembraneous calcium influx and are potent arterial vasodilators. High blood pressure is lowered through a reduction of elevated systemic vascular resistance but, in contrast to other direct acting vasodilators, without clinically relevant sympathetic reflex activation. However, subtle changes of sympathetic nervous system activity may codetermine the acute and chronic blood pressure response. Calcium antagonists do not lead to volume retention, because of improved intrarenal hemodynamics and a diuretic effect. Interference with angiotensin and sympathetically mediated vasoconstrictor mechanisms probably also contributes to their antihypertensive effects. This favorable hemodynamic profile renders calcium antagonists suitable for monotherapy of uncomplicated hypertension where they are particularly effective in older patients and also for the therapy of hypertensive crisis.